Buy or sell Syapse stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Syapse Stock
Real-World Evidence Company
About Syapse Stock
Syapse works with health systems to implement precision medicine programs across their organizations, enabling oncologists to deliver personalized care to every patient who needs it.
Investors
Amgen Ventures
Ascension Ventures
GE Ventures
View, Pivotal, Virgin Hyperloop One, Desktop Metal, Omada Health, Rethink Robotics, Catalant, Syapse, Stem, Sonnen
Intermountain Healthcare Innovation Fund
Medidata Solutions
Roche Venture Fund
Social Capital
Slack, Netskope, Box, BetterUp, Greenlight, Groq, Clover Health, mParticle, Standard Cognition, Intercom
Social Capital Partners
Funding History
| January 2011 | $1.6M |
|---|---|
| January 2013 | $3.0M |
| July 2014 | $10.0M |
| January 2016 | $25.0M |
| November 2017 | $30.0M |
| January 2019 | $20.0M |
| May 2020 | $30.0M |
Management
Chief Executive Officer
Ken Tarkoff
Chief Financial Officer
Fletcher Payne
Chief Technology Officer
Tony Loeser
Press
biospace - Oct, 6 2021
syapse - Nov, 15 2020
syapse - Sep, 9 2020
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Syapse or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
